TEBOTELIMAB

UNII:	L62556GPXB
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TEBOTELIMAB
GSRS Full Record:	L62556GPXB i

2245725-04-4
IMMUNOGLOBULIN G4 (24-ARGININE,278-PROLINE), BISPECIFIC TETRAVALENT, ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3) (HUMAN-MUS MUSCULUS MONOCLONAL MGD013 LIGHT CHAIN VL FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER 1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL MGD013 HEAVY CHAIN VH FRAGMENT), FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER 2) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC E-COIL DOMAIN FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN .GAMMA.4-CHAIN C REGION C-TERMINAL FRAGMENT MUTEIN, DISULFIDE WITH IMMUNOGLOBULIN (26-SERINE) ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL MGD013 LIGHT CHAIN VL FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER 1) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3) (HUMAN-MUS MUSCULUS MONOCLONAL MGD013 HEAVY CHAIN VH FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC LINKER 2) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC K-COIL DOMAIN FRAGMENT), DIMER
MABFRAG HUMAN (FC)MABFRAG HUMANIZED (FAB) ANTI Q15116 (PDCD1_HUMAN)MABFRAG HUMANIZED (FAB) ANTI P18627 (LAG3_HUMAN) (MGD013)
MGD-013
MGD013
MGD013 (PD-1 X LAG-3)
MGD013 DUAL-AFFINITY RE-TARGETING (DART)
Tebotelimab [WHO-DD]
tebotelimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TEBOTELIMAB

Synonyms and Mappings

Resources